Journal of Clinical Oncology
Study identifies possible new acute leukemia marker, treatment target
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal ...
Cancer
May 13, 2013 |
not rated yet |
0
Genetic test helps predict risk of prostate cancer recurrence
(Medical Xpress)—Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
Cancer
May 10, 2013 |
not rated yet |
0
Scientists isolate egg-producing stem cells from adult human ovaries
For the first time, Massachusetts General Hospital (MGH) researchers have isolated egg-producing stem cells from the ovaries of reproductive age women and shown these cells can produce what appear to be normal egg cells or ...
Medical research
Feb 26, 2012 |
5 / 5 (4) |
1
|
Experimental drug beneficial in NIH trial to treat a rare sarcoma
(Medical Xpress)—Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from ...
Cancer
May 07, 2013 |
not rated yet |
0
Benefits of prostate-specific antigen testing remain unclear
(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, ...
Cancer
Jul 20, 2012 |
not rated yet |
3
|
No higher risk of acute leukaemia in close relatives
(Medical Xpress) -- Parents, siblings and children of patients with the most common form of acute leukemia do not run a higher risk of developing the disease as was once believed, according to a new study from the Swedish ...
Cancer
Dec 15, 2011 |
5 / 5 (2) |
0
|
Study suggests patients with lung cancer who carry specific HER2 mutations may benefit from certain anti-HER2 treatments
New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced ...
Cancer
Apr 22, 2013 |
not rated yet |
0
Mammograms reveal response to common cancer drug
Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, ...
Cancer
Apr 22, 2013 |
not rated yet |
0
Hopes that new substance will induce cancer cell suicide
(Medical Xpress)—The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells ...
Cancer
Sep 18, 2012 |
not rated yet |
0
|
First prospective analysis links breast and pancreatic cancer risk with Lynch syndrome
A new prospective study of patients with Lynch syndrome – an inherited disorder of cancer susceptibility caused by mutations in specific DNA repair genes – provides the first strong evidence that people with Lynch ...
Cancer
Feb 13, 2012 |
not rated yet |
0
Ketamine—an established cancer-pain drug—may do more harm than good
(Medical Xpress)—A drug which for decades has been widely used to treat pain related to cancer has no net clinical benefit, researchers in the Palliative Care Clinical Studies Collaborative (PaCCSC) based ...
Cancer
Sep 25, 2012 |
3.7 / 5 (3) |
0
Better long-term outcomes with low hep C viral load
(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, ...
Diseases, Conditions, Syndromes
Mar 25, 2013 |
not rated yet |
0
New brain cancer treatment may be more effective, less toxic
(Medical Xpress)—A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to ...
Cancer
Apr 09, 2013 |
not rated yet |
0
|
Smoking worsens outcomes with advanced colon cancer
(HealthDay)—Smoking is tied to significantly shorter disease-free survival (DFS) and time to recurrence (TTR) in patients undergoing treatment for stage III colon cancer, according to a study published ...
Cancer
Apr 06, 2013 |
5 / 5 (1) |
2
Improved diagnostic test benefits children with acute myeloid leukemia
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research ...
Cancer
Sep 10, 2012 |
not rated yet |
0
